Editorial: Transition care in primary immunodeficiencies

• Siobhan Oisin Burns,
• Siobhan Oisin Burns,
• Nizar Mahlaoui,
• Nizar Mahlaoui,
• Nizar Mahlaoui

Affiliations

Siobhan Oisin Burns

Institute of Immunity and Transplantation, Division of Infection and Immunity, University College London, London, United Kingdom

Siobhan Oisin Burns

Royal Free London National Health System (NHS) Foundation Trust, London, United Kingdom

Nizar Mahlaoui

Pediatric Immuno-Hematology and Rheumatology Unit, Necker-Enfants University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France

Nizar Mahlaoui

French National Reference Center for Primary Immunodeficiencies (CEREDIH), Necker-Enfants University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France

Nizar Mahlaoui

Transition Care platform for Adolescents and Young Adults with Rare or Chronic Diseases « La Suite », Necker-Enfants University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France